{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:28:48Z","timestamp":1789536528266,"version":"build-2803163510"},"reference-count":23,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2025-0675_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to evaluate the pattern, extent, and progression of left- and right-sided cardiac involvement in patients with mucopolysaccharidosis followed in a single tertiary center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0675_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>45 patients (24 males, 21 females) with enzymatically confirmed MPS (Types I, II, III, IV, and VI) followed between 2000 and 2018 were evaluated. Demographic data, consanguinity, clinical characteristics, electrocardiographic (ECG) and echocardiographic findings, and treatment data, including enzyme replacement therapy (ERT), were collected from medical records. Cardiac pathologies were characterized by echocardiography and chest radiography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0675_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age at diagnosis was 6.64\u00a0\u00b1\u00a05.07 years. A high rate of consanguinity was observed: 73\u202f% of parents had consanguineous marriages, including 40\u202f% first-degree and 22.22\u202f% second-degree. The most frequent cardiac findings were mitral insufficiency (53.3\u202f%), and aortic insufficiency (35.6\u202f%). ECG revealed sinus rhythm in all patients, with no conduction abnormalities. Mitral insufficiency was significantly more frequent in patients with pectus carinatum (100 vs. 40\u202f% in those without pectus carinatum; p=0.023). Similarly, aortic insufficiency was significantly more frequent in patients with kyphoscoliosis (63.64 vs. 23.81\u202f%; p=0.027).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0675_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cardiac involvement is frequent and clinically significant in MPS. The left-sided cardiac pathology did not deteriorate during follow-up, whereas progression was observed in right-sided cardiac involvement. Regular, systematic cardiac evaluation is essential in all MPS subtypes. The findings also underscore the importance of genetic counseling in populations with high consanguinity to improve early diagnosis and guide long-term management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2025-0675","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:32:10Z","timestamp":1778585530000},"page":"472-481","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac involvement across mucopolysaccharidosis subtypes: insights from a longitudinal single-center study"],"prefix":"10.1515","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-5264","authenticated-orcid":false,"given":"Dilek","family":"Borakay","sequence":"first","affiliation":[{"name":"Department of Pediatric Cardiology , 668971 Kocaeli City Hospital , Kocaeli , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1050-9922","authenticated-orcid":false,"given":"Mushkinaz","family":"Karimova","sequence":"additional","affiliation":[{"name":"Department of Pediatric Genetics , School of Medicine, Marmara University , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4352-4712","authenticated-orcid":false,"given":"Bilge","family":"Noyan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nutrition and Metabolic Diseases , Sancaktepe Prof. Dr. Ilhan Varank Education Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3836-3117","authenticated-orcid":false,"given":"Figen","family":"Akalin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology , School of Medicine, Marmara University , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0051-6720","authenticated-orcid":false,"given":"Huriye Nursel","family":"Elcioglu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Genetics , School of Medicine, Marmara University , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"2026060500564537205_j_jpem-2025-0675_ref_001","unstructured":"Scriver, CR, Beaudet, AL, Sly, WS, Valle, D. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 1995:3367\u201398 pp."},{"key":"2026060500564537205_j_jpem-2025-0675_ref_002","unstructured":"Kliegman, RM, Behrman, RE, Jenson, HB, Stanton, BM. Nelson textbook of pediatrics. Philadelphia: Elsevier; 2007."},{"key":"2026060500564537205_j_jpem-2025-0675_ref_003","doi-asserted-by":"crossref","unstructured":"Fernandes, J, Saudubray, JM, Van den Berghe, G, Walter, JH. Inborn metabolic diseases: diagnosis and treatment. Berlin: Springer; 2006.","DOI":"10.1007\/978-3-540-28785-8"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_004","doi-asserted-by":"crossref","unstructured":"Ertas, K, Gul, O, Ergul Bozaci, A, Bilgin, H. Evaluation of aortic elasticity properties in mucopolysaccharidosis patients; effect of enzyme replacement therapy on aortic stiffness. J\u00a0Pediatr Endocrinol Metab 2024;37:701\u20138. https:\/\/doi.org\/10.1515\/jpem-2024-0096.","DOI":"10.1515\/jpem-2024-0096"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_005","doi-asserted-by":"crossref","unstructured":"Dangel, JH. Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders: clinical and echocardiographic findings in 64 patients. Eur J Pediatr 1998;157:534\u20138. https:\/\/doi.org\/10.1007\/s004310050872.","DOI":"10.1007\/s004310050872"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_006","unstructured":"K\u0131l\u0131\u00e7, M, Sivri, HSK, Tokatli, A, Dursun, A, Co\u015fkun, T. Mukopolisakkaridozlar: 3 y\u0131ll\u0131k hacettepe deneyimi. J\u00a0LSD 2010;2:83."},{"key":"2026060500564537205_j_jpem-2025-0675_ref_007","doi-asserted-by":"crossref","unstructured":"Braunlin, EA, Harmatz, PR, Scarpa, M, Furlanetto, B, Kampmann, C, Loehr, JP, et al.. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J\u00a0Inherit Metab Dis 2011;34:1183\u201397. https:\/\/doi.org\/10.1007\/s10545-011-9359-8.","DOI":"10.1007\/s10545-011-9359-8"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_008","doi-asserted-by":"crossref","unstructured":"Cimaz, R, La Torre, F. Mucopolysaccharidoses. Curr Rheumatol Rep 2014;16:389. https:\/\/doi.org\/10.1007\/s11926-013-0389-0.","DOI":"10.1007\/s11926-013-0389-0"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_009","doi-asserted-by":"crossref","unstructured":"Teke Kisa, P, Kose, E, Atesoglu, M, Arslan, N. Evaluation of demographic and clinical characteristics of patients with mucopolysaccharidosis. J\u00a0Pediatr Res 2017;4:59\u201362. https:\/\/doi.org\/10.4274\/jpr.15870.","DOI":"10.4274\/jpr.15870"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_010","doi-asserted-by":"crossref","unstructured":"Wraith, JE, Beck, M, Lane, R, Van der Ploeg, A, Shapiro, E, Xue, Y, et al.. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5\u00a0years. Pediatrics 2007;120:e37\u201346. https:\/\/doi.org\/10.1542\/peds.2006-2156.","DOI":"10.1542\/peds.2006-2156"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_011","doi-asserted-by":"crossref","unstructured":"Braunlin, EA, Tolar, J, Mackey-Bojack, S, Masinde, T, Krivit, W, Schoen, FJ. Clear cells in the atrioventricular valves of infants with severe mucopolysaccharidosis (hurler syndrome). Cardiovasc Pathol 2011;20:315\u201321. https:\/\/doi.org\/10.1016\/j.carpath.2010.06.004.","DOI":"10.1016\/j.carpath.2010.06.004"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_012","doi-asserted-by":"crossref","unstructured":"Erta\u015f, K, G\u00fcl, \u00d6, Bozac\u0131, AE, Bilgin, H. Evaluation of cardiac function in pediatric patients diagnosed with mucopolysaccharidosis (MPS) and use of annular plane systolic excursion (APSE) to evaluate systolic function. Mol Genet Metabol 2025;144:109069. https:\/\/doi.org\/10.1016\/j.ymgme.2025.109069.","DOI":"10.1016\/j.ymgme.2025.109069"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_013","doi-asserted-by":"crossref","unstructured":"Dehghan, B, Rostampour, N, Sedighi, M, Saryazdi, MH, Rizi, MJ, Mostofizadeh, N, et al.. Evaluation of cardiac findings in mucopolysaccharidosis. Int J Cardiovasc Imag 2024;40:73\u20138. https:\/\/doi.org\/10.1007\/s10554-023-02983-y.","DOI":"10.1007\/s10554-023-02983-y"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_014","doi-asserted-by":"crossref","unstructured":"Fesslova, V, Corti, P, Sersale, G, Rovelli, A, Russo, P, Mannarino, S, et al.. The natural course and impact of therapies on cardiac involvement\u00a0in mucopolysaccharidoses. Cardiol Young 2009;19:170\u20138. https:\/\/doi.org\/10.1017\/s1047951109003576.","DOI":"10.1017\/S1047951109003576"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_015","doi-asserted-by":"crossref","unstructured":"Azevedo, AC, Schwartz, IV, Kalakun, L, Brustolin, S, Burin, MG, Beheregaray, AP, et al.. Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI. Clin Genet 2004;66:208\u201313. https:\/\/doi.org\/10.1111\/j.1399-0004.2004.00277.x.","DOI":"10.1111\/j.1399-0004.2004.00277.x"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_016","doi-asserted-by":"crossref","unstructured":"Brooks, DA, Gibson, GJ, Karageorgos, L, Hein, LK, Robertson, EF, Hopwood, JJ. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum. Mol Genet Metabol 2005;85:236\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2005.02.008.","DOI":"10.1016\/j.ymgme.2005.02.008"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_017","doi-asserted-by":"crossref","unstructured":"Pastores, G, Arn, P, Beck, M, Clarke, JT, Guffon, N, Kaplan, P, et al.. The MPS I registry: design, methodology, and early findings. Mol Genet Metabol 2007;91:37\u201347. https:\/\/doi.org\/10.1016\/j.ymgme.2007.01.011.","DOI":"10.1016\/j.ymgme.2007.01.011"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_018","doi-asserted-by":"crossref","unstructured":"Thomas, JA, Beck, M, Clarke, JT, Cox, GF. Childhood onset of scheie syndrome, the attenuated form of mucopolysaccharidosis I. J\u00a0Inherit Metab Dis 2010;33:421\u20137. https:\/\/doi.org\/10.1007\/s10545-010-9113-7.","DOI":"10.1007\/s10545-010-9113-7"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_019","doi-asserted-by":"crossref","unstructured":"Rigante, D, Segni, G. Cardiac structural involvement in mucopolysaccharidoses. Cardiology 2002;98:18\u201320. https:\/\/doi.org\/10.1159\/000064674.","DOI":"10.1159\/000064674"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_020","unstructured":"Karademir, S, B\u00fclb\u00fcl, M, Kapukaya, M. Echographic findings in mycopolysaccharidosis (a case report). Turkiye Klinikleri J Pediatr 1992;1:125\u20137."},{"key":"2026060500564537205_j_jpem-2025-0675_ref_021","doi-asserted-by":"crossref","unstructured":"Aldudak, B, \u00d6zbek, MN, Demirbilek, H, Sayg\u0131, S, \u00c7elik, M, Kan\u011f\u0131n, M. Evaluation of echocardiography and holter electrocardiography findings in patients with mucopolysaccharidosis. J\u00a0Curr Pediatr 2015;13:165\u201370. https:\/\/doi.org\/10.4274\/jcp.43433.","DOI":"10.4274\/jcp.43433"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_022","doi-asserted-by":"crossref","unstructured":"Braunlin, EA, Berry, J, Whitley, C. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 2006;98:416\u201318. https:\/\/doi.org\/10.1016\/j.amjcard.2006.02.047.","DOI":"10.1016\/j.amjcard.2006.02.047"},{"key":"2026060500564537205_j_jpem-2025-0675_ref_023","doi-asserted-by":"crossref","unstructured":"Stepien, KM, Braunlin, EA. Unmet cardiac clinical needs in adult mucopolysaccharidoses. Front Cardiovasc Med. 2022;9:907175, https:\/\/doi.org\/10.3389\/fcvm.2022.907175.","DOI":"10.3389\/fcvm.2022.907175"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0675\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0675\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:57:15Z","timestamp":1780621035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0675\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,16]]},"published-print":{"date-parts":[[2026,5,26]]}},"alternative-id":["10.1515\/jpem-2025-0675"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2025-0675","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}